Montelukast Sandoz

Montelukast Sandoz Indications/Uses

montelukast

Manufacturer:

Sandoz

Distributor:

Zuellig
/
Agencia Lei Va Hong
Full Prescribing Info
Indications/Uses
Chewable Tablet 4-mg and Oral Granules: Children 6 months to 5 years: Treatment for inadequately controlled medication as an additional therapy.
Children 2-5 years: Alternative treatment to inhaled corticosteroids for patients who have not recently taken oral corticosteroids for asthma and as a substitute to inhaled corticosteroids.
Children ≥2 years: Prevention of narrowing of airways triggered by exercise.
Chewable Tablet 5-mg: Children 6 to 14 years: Treatment for inadequately controlled medication as an additional therapy.
Children 6-14 years: Alternative treatment to inhaled corticosteroids for patients who have not recently taken oral corticosteroids for asthma and as a substitute to inhaled corticosteroids.
Children ≥6 years: Prevention of narrowing of airways triggered by exercise.
Film-Coated Tablet 10-mg: Treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom "as-needed" short acting beta-agonists provide inadequate clinical control of asthma. In those asthmatic patients in whom Montelukast Sandoz is indicated in asthma, Montelukast Sandoz Film-Coated Tab 10 mg can also provide symptomatic relief of seasonal allergic rhinitis.
Prophylaxis of asthma in which the predominant component is exercise-induced bronchoconstriction.
Montelukast Sandoz Film-Coated Tab 10 mg is indicated in adults and adolescents from the age of 15 years.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in